HRAS and cervical squamous cell carcinoma: With regard to radiotherapy, Huang et al. [18,29] reported that galectin-1 was an independent prognostic factor for local recurrence and survival after definitive radiotherapy for patients with squamous cell carcinoma of the uterine cervix and that galectin-1 may mediate radioresistance through the H-Ras-dependent pathway involved in DNA damage repair.